Skip to main content
. 2022 Feb 25;17(2):e0264448. doi: 10.1371/journal.pone.0264448

Table 2. Association of olfactory function with eGFR at baseline.

N. Mean eGFR, ml/min per 1.73 m2 (S.D.) Difference in eGFR across olfaction groups (95% CI)
Model 1a P Model 2b P
All participants, n = 2161
Olfactory function
Anosmia 323 72.0 (18.2) -2.68 (-5.01, -0.35) 0.024 -3.00 (-5.25, -0.75) 0.009
Hyposmia 384 73.8 (18.8) -2.17 (-4.32, -0.01) 0.049 -1.87 (-3.94, 0.21) 0.078
Moderate 738 78.1 (18.1) 0.94 (-0.82, 2.71) 0.295 1.15 (-0.55, 2.85) 0.186
Good 716 78.4 (18.0) Reference Reference
Trend P < 0.001 Trend P < 0.001
Participants with baseline eGFR ≥ 60 ml/min per 1.73 m2, n = 1747
Olfactory function
Anosmia 238 80.2 (12.7) -2.38 (-4.29, -0.46) 0.002 -2.35 (-4.25, -0.45) 0.015
Hyposmia 295 81.7 (12.7) -1.26 (-3.00, 0.49) 0.156 -1.18 (-2.89, 0.53) 0.177
Moderate 615 83.9 (13.0) 0.36 (-1.03, 1.75) 0.615 0.54 (-0.84, 1.91) 0.444
Good 599 84.1 (13.1) Reference Reference
Trend P = 0.001 Trend P = 0.003

Abbreviations: eGFR: estimated glomerular filtration rate on the serum creatinine and cystatin C level; S.D.: standard deviation; 95% CI: 95% confidence interval.

a adjusted for age, gender, race, research site, education, smoking status, alcohol consumption, brisk walking

b further adjusted for self-reported general health status, BMI, diabetes, hypertension, cardiovascular diseases, chronic lung diseases, LDL-cholesterol, log-transformed HDL-cholesterol, albumin, antihypertensive drugs, and statins uses.